WebApr 11, 2024 · Bone Biologics is currently focusing its development efforts for its bone graft substitute product on bone regeneration in spinal fusion procedures, while additionally having rights to trauma and osteoporosis applications. For more information, please visit www.bonebiologics.com. Forward-looking Statements WebWhile Bone Biologics has chosen to focus its initial product development efforts in spinal fusion, we believe that this regenerative medicine technology has potential in the broader fields of bone regeneration and repair including osteoporosis and trauma applications. Platform Technology Spine
Bone Biologics - Overview, News & Competitors ZoomInfo.com
WebApr 6, 2024 · Bone Biologics Corporation is a medical device company focused on developing and marketing orthobiologic products. The Company is also focused on bone regeneration in spinal fusion using the recombinant human protein, known as NELL-1/DBX. WebBone Biologics was founded to pursue regenerative medicine for bone. The Company is undertaking groundbreaking work with select strategic partners, building on unprecedented research on the Nell-1 protein that has produced a significant number of studies and public Read More Contact Who is Bone Biologics Headquarters hope lange\u0027s brother david lange
Bone Biologics Prices $5,100,000 Million Underwritten Public …
WebApr 11, 2024 · CONTACT. LHA Investor Relations. Kim Sutton Golodetz. 212-838-3777. [email protected]. TimeLine: Bone Biologics Receives Human Research Ethics Committee Approval to Begin Pilot Clinical Trial with, NB1 … WebApr 11, 2024 · By Brad Sorensen, CFA NASDAQ:BBLG READ THE FULL BBLG RESEARCH REPORT Bone Biologics (NASDAQ:BBLG) announced that it has received approval to begin pilot clinical trials with NB1 in spinal fusion ... WebApr 12, 2024 · Volatility and Risk. Bone Biologics has a beta of 0.75, meaning that its share price is 25% less volatile than the S&P 500. Comparatively, Bionik Laboratories has a beta of -1.2, meaning that its ... long shank octopus hooks